Market Indices
Sector Heatmap
QNTM — Quantum Biopharma Ltd. Class B Subordinate Voting Shares
NasdaqQuantum Biopharma Ltd. Class B Subordinate Voting Shares
- O
- 3.07
- H
- 3.16
- L
- 3.02
- V
- 147.27K
QNTM — Latest News & Headlines
19 StoriesQuantum BioPharma Ltd. (QNTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Quantum BioPharma Ltd. (QNTM) Stock Price, News, Quote & History Yahoo! Finance Canada
Quantum BioPharma Ltd. (QNTM.CN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Quantum BioPharma Ltd. (QNTM.CN) Stock Price, News, Quote & History Yahoo! Finance Canada
Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial - Stock Titan
Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial Stock Titan
Quantum BioPharma Ltd. (QNTM) Market-Manipulation Suits Consolidated; G&E Named Lead Counsel - TradingView
Quantum BioPharma Ltd. (QNTM) Market-Manipulation Suits Consolidated; G&E Named Lead Counsel TradingView
Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Luc - Benzinga
Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Luc Benzinga
Unbuzzd royalties give Quantum BioPharma (QNTM) 7% of sales until payments total $250M, then 3% forever. - Stock Titan
Unbuzzd royalties give Quantum BioPharma (QNTM) 7% of sales until payments total $250M, then 3% forever. Stock Titan
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - markets.businessinsider.com
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis markets.businessinsider.com
Quantum BioPharma signs Thermo Fisher contract for Phase 2 MS trial - Mugglehead Investment Magazine
Quantum BioPharma signs Thermo Fisher contract for Phase 2 MS trial Mugglehead Investment Magazine
Grant & Eisenhofer Appointed Lead Counsel in Lawsuit Alleging CIBC and RBC Manipulated Quantum BioPharma Stock - TradingView
Grant & Eisenhofer Appointed Lead Counsel in Lawsuit Alleging CIBC and RBC Manipulated Quantum BioPharma Stock TradingView
Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial - Benzinga
Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial Benzinga
Quantum BioPharma partners with Thermo Fisher for MS drug trial By Investing.com - Investing.com India
Quantum BioPharma partners with Thermo Fisher for MS drug trial By Investing.com Investing.com India
World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - Yahoo Finance UK
World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum B...
Quantum BioPharma Licensee Unbuzzd Wellness Names "Zappy" Zapolin CEO Ahead of Planned Stock Exchange Lis - Benzinga
Quantum BioPharma Licensee Unbuzzd Wellness Names "Zappy" Zapolin CEO Ahead of Planned Stock Exchange Lis Benzinga
SEC Filings for Oct 5, 2026 - 10-K, 10-Q, 8-K Forms - Stock Titan
SEC Filings for Oct 5, 2026 - 10-K, 10-Q, 8-K Forms Stock Titan
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial - Benzinga
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial Benzinga
Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms - Stock Titan
Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms Stock Titan
Quantum BioPharma Wins Consolidation of Market-Manipulation Lawsuits Against CIBC and RBC - TipRanks
Quantum BioPharma Wins Consolidation of Market-Manipulation Lawsuits Against CIBC and RBC TipRanks
Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial - TipRanks
Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial TipRanks
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial - TipRanks
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial TipRanks